SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Munshi S)
 

Search: WFRF:(Munshi S) > (2010-2014) > International Myelo...

  • Terpos, Evangelos (author)

International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma-Related Bone Disease.

  • Article/chapterEnglish2013

Publisher, publication year, extent ...

  • 2013

Numbers

  • LIBRIS-ID:oai:lup.lub.lu.se:9dc38650-38dd-4f21-afc4-ea95ae6c8fab
  • https://lup.lub.lu.se/record/3804300URI
  • https://doi.org/10.1200/JCO.2012.47.7901DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:art swepub-publicationtype
  • Subject category:ref swepub-contenttype

Notes

  • PURPOSEThe aim of the International Myeloma Working Group was to develop practice recommendations for the management of multiple myeloma (MM) -related bone disease.MethodologyAn interdisciplinary panel of clinical experts on MM and myeloma bone disease developed recommendations based on published data through August 2012. Expert consensus was used to propose additional recommendations in situations where there were insufficient published data. Levels of evidence and grades of recommendations were assigned and approved by panel members.RecommendationsBisphosphonates (BPs) should be considered in all patients with MM receiving first-line antimyeloma therapy, regardless of presence of osteolytic bone lesions on conventional radiography. However, it is unknown if BPs offer any advantage in patients with no bone disease assessed by magnetic resonance imaging or positron emission tomography/computed tomography. Intravenous (IV) zoledronic acid (ZOL) or pamidronate (PAM) is recommended for preventing skeletal-related events in patients with MM. ZOL is preferred over oral clodronate in newly diagnosed patients with MM because of its potential antimyeloma effects and survival benefits. BPs should be administered every 3 to 4 weeks IV during initial therapy. ZOL or PAM should be continued in patients with active disease and should be resumed after disease relapse, if discontinued in patients achieving complete or very good partial response. BPs are well tolerated, but preventive strategies must be instituted to avoid renal toxicity or osteonecrosis of the jaw. Kyphoplasty should be considered for symptomatic vertebral compression fractures. Low-dose radiation therapy can be used for palliation of uncontrolled pain, impending pathologic fracture, or spinal cord compression. Orthopedic consultation should be sought for long-bone fractures, spinal cord compression, and vertebral column instability.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Morgan, Gareth (author)
  • Dimopoulos, Meletios A (author)
  • Drake, Matthew T (author)
  • Lentzsch, Suzanne (author)
  • Raje, Noopur (author)
  • Sezer, Orhan (author)
  • García-Sanz, Ramón (author)
  • Shimizu, Kazuyuki (author)
  • Turesson, IngemarLund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Department of Clinical Sciences, Malmö,Faculty of Medicine(Swepub:lu)medf-itu (author)
  • Reiman, Tony (author)
  • Jurczyszyn, Artur (author)
  • Merlini, Giampaolo (author)
  • Spencer, Andrew (author)
  • Leleu, Xavier (author)
  • Cavo, Michele (author)
  • Munshi, Nikhil (author)
  • Rajkumar, S Vincent (author)
  • Durie, Brian G M (author)
  • Roodman, G David (author)
  • Institutionen för kliniska vetenskaper, MalmöMedicinska fakulteten (creator_code:org_t)

Related titles

  • In:Journal of Clinical Oncology31:18, s. 179-23471527-7755

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view